GEODE CAPITAL MANAGEMENT, LLC
Position in BDTX — Black Diamond Therapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in BDTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,142,904
-$86,140 QoQ
Shares Held
536,575
+6.1% QoQ
Ownership
0.936%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BDTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. BDTX ranks #304 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in BDTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,142,904 | 536,575 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,229,044 | 505,780 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,896,981 | 500,523 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,228,450 | 495,343 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,496,678 | 965,599 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,052,935 | 959,316 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,110,214 | 944,877 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,925,732 | 842,432 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,939,847 | 382,613 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $984,753 | 350,446 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $930,715 | 324,291 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,369,595 | 271,207 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $511,108 | 270,428 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $477,522 | 265,290 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $447,084 | 264,547 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $606,901 | 246,708 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,196,706 | 432,024 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,111,570 | 396,167 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,960,830 | 349,980 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,383,548 | 359,602 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,215,821 | 297,437 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $8,651,096 | 269,925 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,488,756 | 247,726 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,663,170 | 181,764 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,255,405 | 90,397 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||